We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,232

Seven Key Questions in Understanding the Current Regulatory State of HCTPs
  • Foley & Lardner LLP
  • USA
  • March 20 2017

Despite regulations, litigation, and significant draft guidance, the future of regulation of HCTPs remains up in the air. Learn what you need to


HHS and Medicare Asked to Expand Coverage for Genetic Tests
  • Foley & Lardner LLP
  • USA
  • March 16 2017

Fifteen members of Congress have asked the Department of Health and Human Services (HHS) and the Medicare Payment Advisory Commission (Medicare) to


PayorProvider Convergence: Joint Venture Health Plans
  • Foley & Lardner LLP
  • USA
  • March 15 2017

Health Plans and health care providers are getting into each other’s business. This payorprovider convergence has taken different forms


Biosimilar Remedies Not Limited Without Full Patent Dance
  • Foley & Lardner LLP
  • USA
  • March 14 2017

The judge presiding over the pending biosimilar litigation between Janssen and CelltrionHospira has issued guidance regarding the ramifications of a


Key Takeaways From FHA’s Health Law Summit
  • Foley & Lardner LLP
  • USA
  • March 13 2017

Foley recently co-hosted the Florida Hospital Association’s (FHA) 2017 Health Law Summit, which brought together more than 40 in-house attorneys and


Is Obamacare Lite Really Less Calories? What Employers Need to Know
  • Foley & Lardner LLP
  • USA
  • March 13 2017

As predicted, Congress is taking action to repeal andor alter major Sections of the Patient Protection and Affordable Care Act (ACA). To get the


House Committees Reveal Draft of Bill to Modify and Repeal Portions of the Affordable Care Act
  • Foley & Lardner LLP
  • USA
  • March 8 2017

On Monday, two House committees with oversight over health care and taxation, Energy and Commerce and Ways and Means, released draft reconciliation


Will The Avastin Biosimilar Patent Dance Go On?
  • Foley & Lardner LLP
  • USA
  • March 7 2017

Judge Sleet of the U.S. District Court for the District of Delaware has dismissed Genentech’s complaint against Amgen for allegedly failing to comply


One is Not Enough - Infringement Liability under 271(f)(1)
  • Foley & Lardner LLP
  • USA
  • March 6 2017

In Life Technologies Corp. v. Promega Corp., Slip Op. 14-1538 (Feb. 22, 2017), the U.S. Supreme Court held that the supply of a single component of a


Final Disability Claims and Appeals Regulations - Be Prepared to Comply
  • Foley & Lardner LLP
  • USA
  • March 6 2017

In December 2016, the Department of Labor issued final regulations under ERISA governing claims procedures for group disability plans, which will